Intelligence · Clinical Development
Pipeline search results
Programs matching “buprenorphine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 52 pipeline programs matching "buprenorphine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Buprenorphine Injectable Solution - Part A
Indivior Pty Ltd
Healthy
1 trial -
Buprenorphine/Naloxone + BEM/RZR
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
RDC-0313 + Buprenorphine
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
buprenorphine
BRIGHT MINDS BIOSCIENCES INC.
Neonatal Abstinence Syndrome
1 trial -
16 mg buprenorphine with 4 mg naloxone sublingual film
Teva Pharma GmbH
Evaluation of QTc Interval
1 trial -
2.0mg Buprenorphine/0.5mg Naloxone
Indivior Pty Ltd
Hepatic Failure
1 trial -
Behavioral: Buprenorphine/naloxone maintenance (Mtn)
BRIGHT MINDS BIOSCIENCES INC.
Opiate Dependence
1 trial -
Brixadi (Injectable Buprenorphine)
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
Buccal Buprenorphine 300 mcg
BRIGHT MINDS BIOSCIENCES INC.
Analgesia
1 trial -
Buprenorphine
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
28 trials -
Buprenorphine (Subutex)
Indivior Pty Ltd
Opioid Dependency
1 trial -
Buprenorphine + naloxone (Suboxone)
Indivior Pty Ltd
Opiate Dependence
1 trial -
Buprenorphine Extended-Release Injection
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
Buprenorphine transdermal patch
Mundipharma Pty Limited
Osteoarthritis
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Opiate-related Disorders
1 trial -
Buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
2 trials -
Extended-Release Buprenorphine (XRB)
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
Injectable buprenorphine
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
P04843
Indivior Pty Ltd
Opiate Dependence
1 trial -
TM buprenorphine
Indivior Pty Ltd
Opioid-use Disorder
1 trial -
Transmucosal Buprenorphine
Indivior Pty Ltd
Moderate to Severe Opioid-use Disorder
1 trial -
buprenorphine
Indivior Pty Ltd
Hepatitis C, Chronic
1 trial -
buprenorphine
Indivior Pty Ltd
Opiate-related Disorders
1 trial -
buprenorphine/naloxone
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
3 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.